Menopause and Migraines: Understanding Hormonal Impacts
- 3 days ago
- 1 min read
Research Summary
A recent narrative review in the journal Headache explores the complex relationship between migraine and the menopausal transition, highlighting how fluctuating estrogen levels impact migraine occurrence. The review indicates that perimenopause poses unique diagnostic and therapeutic challenges due to hormonal variability and increased cardiometabolic risk. It finds that migraine without aura often improves after menopause, but migraine with aura may persist and elevate the risk of ischemic stroke. Menopausal hormone therapy, especially high-dose oral estrogen, can exacerbate migraines and vascular risk, whereas low-dose transdermal estrogen is considered safer. The review emphasizes the need for tailored treatment approaches and calls for more research on menopause-specific migraine management.
Study Details
👥 Research Team: Korn TF, Bernstein C
📚 Published In: Headache
📅 Publication Date: 2026 Apr 3
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.